Stock Events

Stock Events

China Medical System Hldgs 

€1.2100
17
+€0.02+1.68% Thursday 15:16

Statistics

Day High
1.21
Day Low
1.19
52W High
1.4
52W Low
1.18
Volume
-
Avg. Volume
-
Mkt Cap
2.95B
P/E Ratio
-
Dividend Yield
3.11%
Dividend
0.04

Upcoming

Dividends

3.11%Dividend Yield
Sep 26
€0.02
May 26
€0.02
Sep 25
€0.02
May 25
€0.01
Sep 24
€0.02
10Y Growth
4.94%
5Y Growth
-7.02%
3Y Growth
-21.93%
1Y Growth
6.16%

Earnings

17AugExpected
Q4 2025
Q2 2026
0.03
0.04
0.04
0.05
Expected EPS
0.050824197599999996
Actual EPS
0.051777151305

Financials

18.06%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
986.84MRevenue
178.19MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2M7.STU. It's not an investment recommendation.
Microsoft
5
MSFT
Alphabet
4
GOOGL
Realty Income
3
O
Verizon Communications
3
VZ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.93B
Zai Lab Limited operates in the biopharmaceutical sector within China, focusing on bringing transformative medicines, which puts it in direct competition with China Medical System Holdings in several therapeutic areas.
HUTCHMED (China) Limited
HCM
Mkt Cap2.15B
Hutchison China MediTech Limited, known as Chi-Med, is a biopharmaceutical company that develops cancer and immunological drugs, competing with China Medical System Holdings in the specialty pharma sector.
Sinopharm Group
SHTDY
Mkt Cap6.69B
Shanghai Fosun Pharmaceutical Group is a leading healthcare group in China, offering a wide range of pharmaceutical products and medical services, competing across several of the same markets as China Medical System Holdings.
Repligen
RGEN
Mkt Cap9.95B
Repligen Corporation is a bioprocessing company that, while based in the US, competes globally, including in China, in the biopharmaceutical field, indirectly competing with China Medical System Holdings through its support of biopharmaceutical manufacturing.
Perrigo Company
PRGO
Mkt Cap2.01B
Perrigo Company plc is an Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while it operates in a different segment, it competes in the broader pharmaceutical market, including areas where China Medical System Holdings is active.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc is a global healthcare company that, through its pharmaceuticals and vaccines, competes in various therapeutic areas, including those targeted by China Medical System Holdings.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a Swiss multinational pharmaceutical company that operates globally, including in China, offering products in multiple therapeutic areas that overlap with China Medical System Holdings' portfolio.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing in several therapeutic areas with China Medical System Holdings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical corporation that develops and manufactures healthcare products, including those in areas that compete with China Medical System Holdings' portfolio.

About

CHINA MEDICAL SYS HLDGS
Show more...
CEO
Kong Lam
Employees
6415
Country
Cayman Islands
ISIN
KYG211081248
WKN
000A1JLYP

Listings

SG
SG
8A8.SG
MU
DE
2M7C.MU
STU
DE
2M7C.STU
STU
DE
2M7.STU

0 Comments

Share your thoughts

FAQ

What is China Medical System Hldgs stock price today?▼
The current price of 2M7.STU is €1.21 EUR — it has increased by +1.68% in the past 24 hours. Watch China Medical System Hldgs stock price performance more closely on the chart.
What is China Medical System Hldgs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange China Medical System Hldgs stocks are traded under the ticker 2M7.STU.
What is China Medical System Hldgs market cap?▼
Today China Medical System Hldgs has the market capitalization of 2.95B
When is the next China Medical System Hldgs earnings date?▼
China Medical System Hldgs is going to release the next earnings report on March 16, 2027.
What were China Medical System Hldgs earnings last quarter?▼
2M7.STU earnings for the last quarter are 0.05 EUR per share, whereas the estimation was 0.05 EUR resulting in a +1.88% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is China Medical System Hldgs revenue for the last year?▼
China Medical System Hldgs revenue for the last year amounts to 986.84M EUR.
What is China Medical System Hldgs net income for the last year?▼
2M7.STU net income for the last year is 178.19M EUR.
Does China Medical System Hldgs pay dividends?▼
Yes, 2M7.STU dividends are paid semi-annual. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 3.11%.
How many employees does China Medical System Hldgs have?▼
As of September 04, 2026, the company has 6,415 employees.
In which sector is China Medical System Hldgs located?▼
China Medical System Hldgs operates in the Health & Wellness sector.
When did China Medical System Hldgs complete a stock split?▼
The last stock split for China Medical System Hldgs was on April 27, 2012 with a ratio of 3:2.
Where is China Medical System Hldgs headquartered?▼
China Medical System Hldgs is headquartered in North Point, Cayman Islands.